BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34809643)

  • 1. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature.
    Zou Y; Liu S; Wu J; Sun Z
    World J Surg Oncol; 2021 Nov; 19(1):332. PubMed ID: 34809643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Colon Cancer with Suspected DPD Deficiency Causing Severe Adverse Effects following Adjuvant Chemotherapy with Capecitabine].
    Nagahisa S; Watanabe M; Minagi H; Ogawa T; Araki H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Aoki H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1928-1931. PubMed ID: 35045450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience.
    Peng J; Li W; Zhang R; Lin J; Tang J; Wen Y; Lu Z; Wu X; Pan Z
    Cancer Commun (Lond); 2019 Oct; 39(1):59. PubMed ID: 31619288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Colon Cancer with DPD Deficiency That Showed Severe Myelosuppression by CapeOX Adjuvant Chemotherapy after Colon Resection].
    Watanabe H; Arita S; Takeuchi T; Oshima Y; Koike N
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1661-1664. PubMed ID: 30449859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two Cases of Stage Ⅳ Colorectal Cancer with Long-Term Survival following Single-Agent Chemotherapy with Capecitabine-A Case Reports].
    Suda K; Chiku T; Fukuyama M; Shinoda K; Hashiba H; Sano W; Ando K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1882-1884. PubMed ID: 36733031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
    Hagiwara Y; Yamamoto Y; Inagaki Y; Tomisaki R; Tsuji M; Fukuda S; Fukuda S; Onoda T; Suzuki H; Niisato Y; Tange Y; Ikeda N; Yamada K; Kobayashi M; Akutsu D; Yamada T; Moriwaki T; Narasaka T; Suzuki H; Tsuchiya K
    Intern Med; 2022 Aug; 61(16):2449-2455. PubMed ID: 35110482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
    Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
    Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].
    Diao C; Cheng RC; Zhang JM; Wei XP; Su YJ; Liu QY; Xu JB
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):147-50. PubMed ID: 18646702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of colonoscopy in diagnosis of capecitabine associated ileitis: Two case reports.
    Dao AE; Hsu A; Nakshabandi A; Mandaliya R; Nadella S; Sivaraman A; Mattar M; Charabaty A
    World J Gastrointest Endosc; 2019 May; 11(5):383-388. PubMed ID: 31205599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
    Klimko A; Tieranu CG; Olteanu AO; Preda CM; Ionescu EM
    Cureus; 2021 Apr; 13(4):e14621. PubMed ID: 34055501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine-Associated Terminal Ileitis.
    van Hellemond IEG; Thijs AM; Creemers GJ
    Case Rep Oncol; 2018; 11(3):654-659. PubMed ID: 30483093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
    Haller DG; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Gilberg F; Rittweger K; Schmoll HJ
    J Clin Oncol; 2011 Apr; 29(11):1465-71. PubMed ID: 21383294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of early gastric cancer completely responding to adjuvant chemotherapy for advanced colon cancer].
    Tanaka R; Kameyama H; Nakano M; Ichikawa H; Hanyu T; Nakano M; Ishikawa T; Shimada Y; Sakata J; Kobayashi T; Kosugi S; Minagawa M; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2364-6. PubMed ID: 25731524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
    Glen H; Cassidy J
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):547-51. PubMed ID: 18402521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D; Aghmesheh M; de Souza P; Carolan M; Clingan P; Rose J; Ranson M
    Clin Colorectal Cancer; 2018 Sep; 17(3):e549-e555. PubMed ID: 29861156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.
    Shiroiwa T; Fukuda T; Shimozuma K; Ohashi Y; Tsutani K
    Pharmacoeconomics; 2009; 27(7):597-608. PubMed ID: 19663530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T; Fukuda M; Yasui H; Okazaki S; Kubo K; Tanaka M; Une Y; Setoguchi Y; Hanada K; Moriyama S; Tani M; Murakami T; Okuchi Y; Ogiso S; Hata H; Sakata S; Otani T; Yamato T; Ikai I
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):389-93. PubMed ID: 22421765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
    Sonnenblick A; Meirovitz A
    Int J Clin Oncol; 2010 Aug; 15(4):420-2. PubMed ID: 20217448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.